La Notte dei Ricercatori: 27 November 2020, Sharper Night – event held in 13 cities across Italy for European Researchers’ Night. Tour our labs, meet, and chat online with our Researchers.
Read more
Latest updates
Syncona founds Purespring with a £45m Series A Financing – ICGEB FunSel IP licenced
Syncona Ltd announces the foundation of a new Syncona company, Purespring Therapeutics (Purespring) with a £45.0 million holding, involving ICGEB Intellectual Property.
Read more
ICGEB Cape Town COVID-19 diagnostic testing activities
With the support of New England Biolabs, the ICGEB Cape Town Component received SARS-CoV-2 Rapid Colorimetric LAMP assay kits.
Read more
ICGEB Alumni Unite
ICGEB Alumni perform state-of-the-art research in renowned universities and research institutes the world over and are now coming together to make their presence felt. The ICGEB has reached out to more than 1700 of its graduates over recent weeks to formalise the Alumni Association and the feedback has been overwhelming.
Read more
ICGEB’s Council – science for the world
October 27-28, 2020: ICGEB Trieste, Italy hosted the virtual session of the Council of Scientific Advisers. On the occasion of the 26th session of the Council, we hear from Roger N. Beachy, CSA member and Chair.
Read more
Jubilee Congress “Nicolae Testemitanu” in Moldova airs to over 6000
Among other events, in October 2020, ICGEB was at the 75th Anniversary celebration of the “Nicolae Testemitanu” State University of Medicine and Pharmacy in Chisinau, Moldova, which reached an audience of over 6000.
Read more
COVID-19 lung damage caused by persistence of ‘abnormal cells’
Investigations of deceased COVID-19 patients have shed light on possible lung damage caused by the virus. The latest publication by Mauro Giacca, Serena Zacchigna, and team reports.
Read more
Cytoskeleton may play a pivotal role in autoimmune disorders
The Cell immunology laboratory at ICGEB Trieste has found a role for actin in the early stages of autoimmunity.
Read more
The genome of a double-stranded RNA virus is edited for the first time
Oscar Burrone, ICGEB Trieste, Italy, and collaborators have published findings on the first nuclease-mediated genome editing of Rotavirus, a double-stranded RNA virus, in Cell Reports.
Read more
MSC Cruises to implement “Safe Air” sanitation system developed by FINCANTIERI in collaboration with ICGEB
MSC Seashore is the first cruise liner to feature this advanced air sanitation technology developed by Fincantieri in cooperation with the ICGEB.
Read more
Updates from our Member States on COVID-19/SARS-CoV-2
The ICGEB is providing links and publishing updates from its network in Member States on the Covid-19/SARS-CoV-2 actions being undertaken across the globe on this page for reference.
Read more
ICGEB together with AC Immune: recipients of an EU JNDP grant
Grant from the ‘EU Joint Programme – Neurodegenerative Disease Research’ (JPND) provides €1.45M in funding – among the recipients, ICGEB’s Molecular Pathology lab, headed by Emanuele Buratti. The project aims to investigate a TDP-43 aggregation tracer for diagnostic purposes.
Read more